Vertsman Pharma Consulting Inc is categorized under Business Consultants in River Edge, NJ and active since 2011.
Vertsman Pharma Consulting Inc was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Irina Vertsman at the company’s single location by writing to 255 Jefferson Avenue, River Edge, New Jersey NJ 07661 or by phoning (201) 576-9116. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vertsman Pharma Consulting Inc |
| Contact Person: | Irina Vertsman |
| Address: | 255 Jefferson Avenue, River Edge, New Jersey 07661 |
| Phone Number: | (201) 576-9116 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Vertsman Pharma Consulting Inc was started in 2011 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Irina Vertsman for inquiries that concern Vertsman Pharma Consulting Inc by calling the company number (201) 576-9116, as your correspondence is most welcome. Additionally, the physical location of the single location of Vertsman Pharma Consulting Inc can be found at the coordinates 40.932279,-74.041542 as well as the street address 255 Jefferson Avenue in River Edge, New Jersey 07661.
For its online presence, you may visit Vertsman Pharma Consulting Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.